Literature DB >> 17917148

Stem cells in chronic myeloid leukaemia.

Francesca Pellicano1, Tessa L Holyoake.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17917148     DOI： 10.3233/cbm-2007-34-503

Source DB:  PubMed          Journal:  Cancer Biomark        ISSN： 1574-0153            Impact factor:   4.388


× No keyword cloud information.
  2 in total

1.  Retention but significant reduction of BCR-ABL transcript in hematopoietic stem cells in chronic myelogenous leukemia after imatinib therapy.

Authors:  Akihiro Abe; Yosuke Minami; Fumihiko Hayakawa; Kunio Kitamura; Yuka Nomura; Makoto Murata; Akira Katsumi; Hitoshi Kiyoi; Catriona H M Jamieson; Jean Y J Wang; Tomoki Naoe
Journal:  Int J Hematol       Date:  2008-11-29       Impact factor: 2.490

2.  Abcg2 overexpression represents a novel mechanism for acquired resistance to the multi-kinase inhibitor Danusertib in BCR-ABL-positive cells in vitro.

Authors:  Stefan Balabanov; Artur Gontarewicz; Gunhild Keller; Laura Raddrizzani; Melanie Braig; Roberta Bosotti; Jürgen Moll; Edgar Jost; Christine Barett; Imke Rohe; Carsten Bokemeyer; Tessa L Holyoake; Tim H Brümmendorf
Journal:  PLoS One       Date:  2011-04-26       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.